RESIDUE X4N 72 CONECT C10 4 C09 C11 H101 H102 CONECT N12 3 C13 C11 H121 CONECT C13 3 N12 C08 O14 CONECT C15 4 C02 C16 N22 H151 CONECT C17 4 C20 C16 C18 C19 CONECT C20 4 C17 C21 C16 H201 CONECT C21 4 C20 N22 H212 H211 CONECT C24 4 C23 C25 N29 H241 CONECT C26 4 C25 H261 H263 H262 CONECT C28 4 C25 H281 H283 H282 CONECT C02 3 C15 N03 O01 CONECT C04 4 C05 C07 N03 H041 CONECT C05 3 C04 N06 H051 CONECT C07 4 C04 C08 H071 H072 CONECT C08 4 C13 C07 C09 H081 CONECT C09 4 C10 C08 H092 H091 CONECT C11 4 C10 N12 H111 H112 CONECT C16 4 C15 C17 C20 H161 CONECT C18 4 C17 H183 H181 H182 CONECT C19 4 C17 H192 H191 H193 CONECT C23 3 C24 N22 O36 CONECT C25 4 C24 C26 C28 C27 CONECT C27 4 C25 H273 H271 H272 CONECT C30 3 C31 N29 O35 CONECT C31 4 C30 F32 F33 F34 CONECT F32 1 C31 CONECT F33 1 C31 CONECT F34 1 C31 CONECT N03 3 C02 C04 H031 CONECT N06 2 C05 H061 CONECT N22 3 C15 C21 C23 CONECT N29 3 C24 C30 H291 CONECT O01 1 C02 CONECT O14 1 C13 CONECT O35 1 C30 CONECT O36 1 C23 CONECT H101 1 C10 CONECT H102 1 C10 CONECT H121 1 N12 CONECT H151 1 C15 CONECT H201 1 C20 CONECT H212 1 C21 CONECT H211 1 C21 CONECT H241 1 C24 CONECT H261 1 C26 CONECT H263 1 C26 CONECT H262 1 C26 CONECT H281 1 C28 CONECT H283 1 C28 CONECT H282 1 C28 CONECT H041 1 C04 CONECT H051 1 C05 CONECT H071 1 C07 CONECT H072 1 C07 CONECT H081 1 C08 CONECT H092 1 C09 CONECT H091 1 C09 CONECT H111 1 C11 CONECT H112 1 C11 CONECT H161 1 C16 CONECT H183 1 C18 CONECT H181 1 C18 CONECT H182 1 C18 CONECT H192 1 C19 CONECT H191 1 C19 CONECT H193 1 C19 CONECT H273 1 C27 CONECT H271 1 C27 CONECT H272 1 C27 CONECT H031 1 N03 CONECT H061 1 N06 CONECT H291 1 N29 END HET X4N 72 HETNAM X4N (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopiperidin-3- HETNAM 2 X4N yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroac HETNAM 3 X4N etyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide FORMUL X4N C24 H36 F3 N5 O4